ATE83151T1 - Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung. - Google Patents

Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.

Info

Publication number
ATE83151T1
ATE83151T1 AT87113856T AT87113856T ATE83151T1 AT E83151 T1 ATE83151 T1 AT E83151T1 AT 87113856 T AT87113856 T AT 87113856T AT 87113856 T AT87113856 T AT 87113856T AT E83151 T1 ATE83151 T1 AT E83151T1
Authority
AT
Austria
Prior art keywords
manufacture
cell membrane
membrane proteins
preparations containing
lymphocytes
Prior art date
Application number
AT87113856T
Other languages
English (en)
Inventor
Irun Robert Cohen
Meir Shinitzky
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority claimed from EP87113856A external-priority patent/EP0261648B1/de
Application granted granted Critical
Publication of ATE83151T1 publication Critical patent/ATE83151T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT87113856T 1983-09-11 1987-09-22 Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung. ATE83151T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL69686A IL69686A (en) 1983-09-11 1983-09-11 Compositions containing cell membrane proteins and process for their preparation
US06/910,876 US4996194A (en) 1983-09-11 1986-09-23 Pressure treated autoimmune specific T cell compositions
EP87113856A EP0261648B1 (de) 1986-09-23 1987-09-22 Zellmembranproteine, Zubereitungen, die sie enthalten und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE83151T1 true ATE83151T1 (de) 1992-12-15

Family

ID=37781888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87113856T ATE83151T1 (de) 1983-09-11 1987-09-22 Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.

Country Status (9)

Country Link
US (2) US4634590A (de)
JP (1) JPH0641421B2 (de)
AT (1) ATE83151T1 (de)
CA (1) CA1235660A (de)
DE (1) DE3433339C2 (de)
FR (1) FR2553100B1 (de)
GB (1) GB2146338B (de)
IL (1) IL69686A (de)
IT (1) IT1210493B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
USRE35277E (en) * 1983-09-11 1996-06-18 Yeda Research And Development Co. Ltd. Cell membrane proteins, compositions containing them and procedure for their preparation
US4931275A (en) * 1985-12-02 1990-06-05 Yeda Research & Development Co., Ltd. Anti-tumor vaccines and their preparation
GB8610983D0 (en) * 1986-05-06 1986-06-11 Connaught Lab Enhancement of antigen immunogenicity
FR2600068B1 (fr) * 1986-06-12 1990-03-23 Pasteur Institut Polypeptides de surfaces cellulaires, isoles et purifies, reconnus par les anticorps responsables de la pathogenie du lupus erythemateux dissemine (led), leur methode d'obtention et leur application au diagnostic ou led
JPS63258495A (ja) * 1986-06-12 1988-10-25 インスティチュ−ト・パスツ−ル ポリペプチド組成物、その製法、それを用いる試験法、それを含む診断用キット及びそれに対する抗体
DE3782996T2 (de) * 1986-09-23 1993-06-09 Yeda Res & Dev Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
EP0291046A1 (de) * 1987-05-12 1988-11-17 Yeda Research And Development Company Limited Überwachung der Wirksamkeit einer Impfung
US6039947A (en) * 1987-06-24 2000-03-21 Autoimmune, Inc. Peptides derived from immunodominant epitopes of myelin basic protein
DE68926294T2 (de) * 1988-02-18 1996-09-19 Ks Biomedix Ltd Antigen gegen diabetes
IL85746A (en) * 1988-03-15 1994-05-30 Yeda Res & Dev Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
US5582831A (en) * 1991-11-26 1996-12-10 Yeda Research And Development Co., Ltd. Anti-tumor vaccines
ES2051989T3 (es) * 1988-10-21 1994-07-01 Akzo Nv Un procedimiento para la manufactura de una inmunotoxina para el tratamiento o profilaxis de una enfermedad autoinmune.
NO306996B1 (no) * 1989-02-17 2000-01-24 Bayer Ag Isolert bukspyttkjerteloey-celle-(ICA)-antigen for in vitro- bruk
IL89431A0 (en) * 1989-02-27 1989-09-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of autoimmune diseases
US6464978B1 (en) 1989-03-21 2002-10-15 The Immune Response Corporation Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US5858980A (en) * 1990-03-30 1999-01-12 Autoimmune, Inc. Peptide fragments of myelin basic protein
IL99589A0 (en) * 1990-10-03 1992-08-18 Yeda Res & Dev T cell vaccination for prevention and treatment of allergy or graft rejection
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5723503A (en) * 1994-09-28 1998-03-03 Thomas Jefferson University Biological treatment for rheumatoid arthritis
US6033661A (en) 1995-06-07 2000-03-07 Thomas Jefferson University Composition and method for allogenetic mononuclear cell immunotherapy
US5674487A (en) * 1994-09-28 1997-10-07 Univ Jefferson Method for treating autoimmune diseases
JPH0924269A (ja) * 1995-07-10 1997-01-28 M Technic Kk リン脂質を使ったマイクロカプセルの製造方法
WO1997036614A1 (en) * 1996-03-29 1997-10-09 Terman David S Polymerized staphylococcal protein a for treatment of diseases
US6676686B2 (en) 2000-04-25 2004-01-13 Harumi Naganuma Noninvasive detection and activation of the lymphatic system in treating disease and alleviating pain
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
ES2545736T3 (es) * 2002-08-08 2015-09-15 Baylor College Of Medicine Aislamiento e identificación de células T
DK2016414T3 (en) * 2006-05-05 2015-12-07 Opexa Therapeutics T-cell vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
JPS53139720A (en) * 1977-05-11 1978-12-06 Green Cross Corp:The Production of antihumanlymphociteglobulin (ahlg)
JPS5524133A (en) * 1978-08-09 1980-02-21 Atsushi Kondo Preparation of anti-human lymphocyte globulin
US4381295A (en) * 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4390623A (en) * 1980-10-02 1983-06-28 Hooper Trading Company Serum-free and mitogen-free T-cell growth factor and process for making same
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
US4406830A (en) * 1981-04-17 1983-09-27 Shanksville Corporation, N.V. Regulatory glycoprotein for immune response and the use thereof in the production of T-cell growth factor
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
GB8422869D0 (en) 1984-10-17
FR2553100A1 (fr) 1985-04-12
FR2553100B1 (fr) 1989-09-01
IT8422580A0 (it) 1984-09-07
JPH0641421B2 (ja) 1994-06-01
IL69686A0 (en) 1983-12-30
IL69686A (en) 1988-03-31
CA1235660A (en) 1988-04-26
GB2146338B (en) 1988-04-07
US4996194A (en) 1991-02-26
IT1210493B (it) 1989-09-14
DE3433339C2 (de) 1994-02-03
GB2146338A (en) 1985-04-17
US4634590A (en) 1987-01-06
JPS60155126A (ja) 1985-08-15
DE3433339A1 (de) 1985-03-28

Similar Documents

Publication Publication Date Title
ATE83151T1 (de) Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
ATE15798T1 (de) Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit.
PH17552A (en) Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines,their pharmaceutical compositions and method of use
FR2511357B1 (fr) Cis-platine microcristallin, son procede de preparation et composition pharmaceutique le contenant
ATE8790T1 (de) Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
OA07419A (fr) Activateur de plamimogène de tissu humain, son procédé de production et composition pharmaceutique le contenant.
IL58759A (en) Process for purifying proteins,pure and homogeneous interferon species obtained thereby and pharmaceutical compositions containing them
DE3061586D1 (en) Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
ATE39251T1 (de) 3-(4-piperidyl)-1,2-benzisoxazole, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
PT76314B (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
DE3070278D1 (en) Peptides, processes for their preparation and pharmaceutical compositions containing them
IL47268A (en) Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them
DE3782996D1 (de) Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.
BE864027A (fr) Procede de preparation de l'alpha-2,5,9-trimethylbenzo-(b)-thieno-(2,3,f)-morphane, produit obtenu et composition pharmaceutique le contenant
IL65396A0 (en) Esters of mercapto acyl-carnitines,process for their preparation and pharmaceutical compositions containing same
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
IL59857A (en) Monohydrate of 1alpha,25-dihydroxycholecalciferol,process for preparing it and pharmaceutical compositions containing it
IL59842A (en) Biologically active substance 41,200 rp obtained from cells of a micrococcus sedogenes m 78,a process for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties